科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Journal of Clinical Oncology2026-01-20· Medicine

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1

Mary-Ellen Taplin, Irbaz Bin Riaz, R. Bryan Rumble, Syed Arsalan Ahmed Naqvi, MD Thomas A. Hope, Mariane Fontes Dias, Huan He, Sebastién J. Hotte, Hamid Emamekhoo, M. Hassan Murad, Paul Celano, Terry M. Kungel, Steve Hentzen, Michael Serzan, Rahul A. Parikh

原始摘要(英文原文)· Original abstract
This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found at www.asco.org/genitourinary-cancer-guidelines .
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1 — 科研速览 Science Skim